| A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer (NCT01874938) | Eli Lilly and Company | 2013-08-01 |
| "Phase III Randomized Trial Comparing D2 vs D3 Lymphadenectomy With Gastric Cancer Following Neoadjuvant Chemotherapy (NCT02139605) | Tata Memorial Centre | 2013-07-05 |
| FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer (NCT01913639) | Memorial Sloan Kettering Cancer Center | 2013-07-01 |
| Lauren Classifications and HER2 Status in Gastric Cancer Patients (NCT01927146) | Sun Yat-sen University | 2013-07-01 |
| Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study. (NCT02078700) | Azienda USL Reggio Emilia - IRCCS | 2013-07-01 |
| A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer (NCT01774786) | Hoffmann-La Roche | 2013-06-10 |
| Her 2 Testing in Indian Patients With Gastric Cancer (NCT01814345) | Tata Memorial Hospital | 2013-06-01 |
| New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy (NCT01896310) | Shandong University | 2013-06-01 |
| Neoadjuvant Chemoradiotherapy vs. Chemotherapy Followed by Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer (NCT01815853) | Sun Yat-sen University | 2013-06-01 |
| Perioperative Application of Omega-3 Polyunsaturated Fatty Acids in Gastric Cancer Patients (NCT01910948) | Jian Suo | 2013-06-01 |
| Gastric Partitioning Procedure for the Treatment of Unresectable and Obstructive Distal Gastric Cancer (NCT02064803) | Instituto do Cancer do Estado de São Paulo | 2013-06-01 |
| Circulating Tumor Cells (CTCs) in Advanced Gastric Cancer (NCT01848015) | Peking University | 2013-06-01 |
| Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer (NCT01813253) | Kuhnil Pharmaceutical Co., Ltd. | 2013-05-13 |
| Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer (NCT01889303) | Wuhan University | 2013-05-01 |
| Extensive Peritoneal Lavage After Curative Gastrectomy for Gastric Cancer: A Randomised Controlled Trial (NCT02140034) | National University Hospital, Singapore | 2013-05-01 |
| Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors (NCT01803503) | National University Hospital, Singapore | 2013-05-01 |
| A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer (NCT02817425) | LanZhou University | 2013-05-01 |
| A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric Cancer (NCT01839500) | Hoffmann-La Roche | 2013-04-25 |
| S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients (NCT01824459) | Sun Yat-sen University | 2013-04-01 |
| Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery (NCT01838109) | Seoul National University Hospital | 2013-04-01 |
| A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer (NCT01836120) | Hebei Tumor Hospital | 2013-04-01 |
| Early Jejunostomy Nutrition Minimizes Time to Chemotherapy (NCT01766765) | Jinling Hospital, China | 2013-04-01 |
| Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality (NCT02047994) | International Agency for Research on Cancer | 2013-03-01 |
| Clinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric Cancer (NCT01743365) | Hellenic Cooperative Oncology Group | 2013-02-11 |
| Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial (NCT01761461) | Samsung Medical Center | 2013-02-06 |
| Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer (NCT01783951) | Capital Medical University | 2013-02-01 |
| Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis (NCT01962376) | Hebei Medical University | 2013-02-01 |
| The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer (NCT01787539) | Medical University of Lublin | 2013-02-01 |
| Predicting Gastric Cancer Response to Chemo With Multimodal AI Model (NCT06451393) | Sixth Affiliated Hospital, Sun Yat-sen University | 2013-02-01 |
| A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancer (NCT01748773) | Hoffmann-La Roche | 2013-01-29 |
| The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical Study (NCT02583659) | Huazhong University of Science and Technology | 2013-01-01 |
| FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer (NCT01747551) | Dana-Farber Cancer Institute | 2013-01-01 |
| Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients ("EXO-PPP Study") (NCT01779583) | Hospital Miguel Servet | 2013-01-01 |
| Evaluation of the Efficacy of Distal Gastrectomy for the Treatment of Gastric Cancer (a Case Series) (NCT05068635) | Sylvestre KABURA | 2013-01-01 |
| Feasibility Study of Intraperitoneal Paclitaxel (NCT01739894) | National University Hospital, Singapore | 2013-01-01 |
| Annual Hospital Volume and and Short-term Postoperative Outcomes After Gastric Cancer Resection (NCT07072429) | Cantonal Hospital of St. Gallen | 2013-01-01 |
| Long-term Outcomes of Open Versus Laparoscopic Distal Gastrectomy for T4a Gastric Cancer (NCT05493358) | University Medical Center Ho Chi Minh City (UMC) | 2013-01-01 |
| A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC) (NCT01702558) | Hoffmann-La Roche | 2012-12-03 |
| XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach (NCT01798251) | Harbin Medical University | 2012-12-01 |
| A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors (NCT01764087) | Hanmi Pharmaceutical Company Limited | 2012-12-01 |
| S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer (NCT01671449) | Min-Hee Ryu | 2012-12-01 |
| Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer. (NCT01715233) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-12-01 |
| Impact of Preoperative VFA on Intraoperative Adverse Events in Patients Undergoing Laparoscopic Radical Gastrectomy (NCT06506331) | Fujian Medical University | 2012-12-01 |
| The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI Cancer (NCT01863420) | Chinese Academy of Medical Sciences | 2012-11-01 |
| A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer (NCT01662869) | Hoffmann-La Roche | 2012-11-01 |
| First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma (NCT01697072) | Amgen | 2012-10-01 |
| Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancer (NCT01718626) | Hebei Tumor Hospital | 2012-10-01 |
| Comparison of Delta-Shaped and Billroth II After TLDG (NCT02372747) | The First Hospital of Jilin University | 2012-10-01 |
| Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric Cancer (NCT01742806) | Yonsei University | 2012-10-01 |
| Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03) (NCT01584336) | Soonchunhyang University Hospital | 2012-10-01 |
| Predictive Biomarkers in Stage II/III Gastric Cancer for Adjuvant Chemotherapy (NCT01905969) | Iwate Medical University | 2012-10-01 |
| CT Perfusion Changes in GI Cancer During Adenosine Vasodilation Test (NCT02074124) | University of Copenhagen | 2012-10-01 |
| Aberrant DNA Methylation to Predict Metachronous Gastric Neoplasms (NCT04830618) | Seoul National University Hospital | 2012-09-11 |
| A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer (NCT01641939) | Hoffmann-La Roche | 2012-09-03 |
| Identifying Saliva Markers of Patients With Stomach, Colorectal (Including Pre-cancer Polyp) and Pancreatic Cancers (NCT01675258) | Hadassah Medical Organization | 2012-09-01 |
| Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours (NCT01795768) | Royal Marsden NHS Foundation Trust | 2012-09-01 |
| Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer (NCT01683864) | University Hospital Tuebingen | 2012-09-01 |
| Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1 (NCT01719549) | Asan Medical Center | 2012-09-01 |
| Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer (NCT01747707) | Chinese Academy of Medical Sciences | 2012-09-01 |
| Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy (NCT01938313) | Seoul National University Bundang Hospital | 2012-08-01 |
| A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC (NCT01963702) | Fudan University | 2012-08-01 |
| Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes (NCT01637350) | Tianjin Medical University Cancer Institute and Hospital | 2012-08-01 |
| Functional Jejunal Interposition Improve Nutritional Status After Total Gastrectomy (NCT01996059) | Sun Yat-sen University | 2012-07-01 |
| Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total Gastrectomy (NCT01433861) | Seoul National University Bundang Hospital | 2012-07-01 |
| Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors (NCT01576666) | Novartis Pharmaceuticals | 2012-07-01 |
| A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer (NCT01590719) | Hoffmann-La Roche | 2012-07-01 |
| The Efficacy of Topical Bupivacaine and Triamcinolone Acetonide Injection in the Relief of Pain After Endoscopic Submucosal Dissection for Gastric Neoplasia: A Randomized Double-blind, Placebo-controlled Trial (NCT01961752) | Yonsei University | 2012-07-01 |
| Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery (NCT01655641) | Tribhuvan University Teaching Hospital, Institute Of Medicine. | 2012-07-01 |
| Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer (NCT01625702) | Peking University | 2012-06-01 |
| Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer (NCT01522768) | Memorial Sloan Kettering Cancer Center | 2012-03-01 |
| A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2 (NCT01614522) | ASLAN Pharmaceuticals | 2012-03-01 |
| Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric Carcinoma (NCT02024217) | Fudan University | 2012-03-01 |
| Perioperative Chemotherapy for Potentially Resectable Gastric Cancer (NCT01516944) | Hebei Medical University | 2012-02-01 |
| The Efficacy of Health Partnership Program for Cancer Patients (NCT01527409) | National Cancer Center, Korea | 2012-02-01 |
| Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer (NCT02229058) | Sun Yat-sen University | 2012-02-01 |
| S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer (NCT01498289) | SWOG Cancer Research Network | 2012-02-01 |
| Comparative Study on the Effects of Epidural Dexmedetomidine on Heart Rate Variability During General Anesthesia in Patients Undergoing Gastrectomy (NCT01857141) | Yonsei University | 2012-02-01 |
| Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric Cancers (NCT01650766) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2012-02-01 |
| Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes (NCT01528059) | feng Zheng | 2012-02-01 |
| Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer (NCT01611506) | Dr Anna Dorothea Wagner | 2012-02-01 |
| RCT: WLE vs. NBI in Upper Gastrointestinal Endoscopy (NCT01945177) | Changi General Hospital | 2012-01-01 |
| TOF Versus SOX in Metastatic Gastric Cancer (NCT02442362) | The First People's Hospital of Changzhou | 2012-01-01 |
| Prognostic Values of Inflammation-based Indices in Gastric Cancer (NCT05075421) | Gulhane Training and Research Hospital | 2012-01-01 |
| D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer (NCT01836991) | Zhejiang Cancer Hospital | 2012-01-01 |
| Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma (NCT01711242) | xie congying | 2012-01-01 |
| Efficacy of Preoperative Nutritional Support on Postoperative Outcome in Gastric Cancer Patients at Nutritional Risk by NRS-2002 (NCT01830907) | The First Hospital of Jilin University | 2012-01-01 |
| Artificial Intelligence for Determination of Gastroscopy Surveillance Intervals (NCT05631015) | Xiuli Zuo | 2012-01-01 |
| Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer (NCT01515748) | Sanofi | 2011-12-30 |
| A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer (NCT01461057) | Hoffmann-La Roche | 2011-12-06 |
| A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer (NCT01450696) | Hoffmann-La Roche | 2011-12-01 |
| Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma (NCT01491698) | Memorial Sloan Kettering Cancer Center | 2011-12-01 |
| Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy (NCT01497964) | Sanofi | 2011-12-01 |
| Efficacy of Laparoscopic Subtotal Gastrectomy With D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (NCT01456598) | Ajou University School of Medicine | 2011-11-21 |
| An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors (NCT01466569) | AbGenomics B.V Taiwan Branch | 2011-11-01 |
| Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer (NCT01457846) | AstraZeneca | 2011-11-01 |
| Safety and Efficacy of Using MASTER to Perform Endoscopic Submucosal Dissection in Human (NCT01464918) | National University Hospital, Singapore | 2011-11-01 |
| Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junction (NCT01468389) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2011-11-01 |
| HIPEC for Peritoneal Carcinomatosis (NCT02040142) | Albert Einstein College of Medicine | 2011-11-01 |
| Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea (NCT02538562) | Hoffmann-La Roche | 2011-10-11 |
| Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia (NCT01471756) | Mayo Clinic | 2011-10-01 |